AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022

Rhea-AI Summary

AngioDynamics, Inc. (NASDAQ: ANGO) announced it will report its second quarter financial results for fiscal year 2022 on January 6, 2022, prior to market open. The management will conduct a conference call at 8:00 a.m. ET on the same day to discuss these results. Interested participants can join by calling 1-877-407-0784 domestically or +1-201-689-8560 internationally, using passcode 13725681. The call will also be accessible via webcast on AngioDynamics' website, with a replay available later that day.

LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the second quarter of fiscal year 2022 before the market open on Thursday, January 6, 2022. The Company’s management will host a conference call at 8:00 a.m. ET the same day to discuss the results.

To participate in the conference call, dial 1-877-407-0784 (domestic) or +1-201-689-8560 (international) and refer to the passcode 13725681.

This conference call will also be webcast and can be accessed from the “Investors” section of the AngioDynamics website at www.angiodynamics.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

A recording of the call will also be available from 11:00 a.m. ET on Thursday, January 6, 2022, until 11:59 p.m. ET on Thursday, January 13, 2022. To hear this recording, dial 1-844-512-2921 (domestic) or +1-412-317-6671 (international) and enter the passcode 13725681.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211215005990/en/

Investor Contact:

AngioDynamics, Inc.

Stephen Trowbridge, Executive Vice President & CFO

(518) 795-1408

Source: AngioDynamics, Inc.

FAQ

When will AngioDynamics report its financial results for Q2 2022?

AngioDynamics will report its Q2 2022 financial results before market open on January 6, 2022.

What time is the AngioDynamics conference call for Q2 2022 results?

The conference call for AngioDynamics' Q2 2022 results will be held at 8:00 a.m. ET on January 6, 2022.

How can I participate in the AngioDynamics conference call?

To participate in the AngioDynamics conference call, dial 1-877-407-0784 domestically or +1-201-689-8560 internationally and use passcode 13725681.

Will the AngioDynamics conference call be available for replay?

Yes, a replay of the AngioDynamics conference call will be available starting at 11:00 a.m. ET on January 6, 2022.

Where can I access the AngioDynamics webcast of the conference call?

The AngioDynamics conference call webcast can be accessed from the 'Investors' section of their website.